Provided by Tiger Fintech (Singapore) Pte. Ltd.

crane

160.39
+1.701.07%
Post-market: 160.390.00000.00%16:20 EDT
Volume:225.47K
Turnover:36.07M
Market Cap:9.13B
PE:31.73
High:161.04
Open:159.37
Low:158.33
Close:158.69
Loading ...

Is Crane Company (NYSE:CR) One of the Best Stocks to Buy According to Billionaire Mario Gabelli?

Insider Monkey
·
12 hours ago

Actinium Pharmaceuticals to Host KOL Investor Call at 8am ET Today to Highlight Revamped Clinical Programs and Expanded Market Opportunities Including Newly Initiated Actimab-A Solid Tumor Program

PR Newswire
·
Yesterday

Actinium Pharmaceuticals Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities

PR Newswire
·
Yesterday

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy

GlobeNewswire
·
24 Mar

CR Construction Group Holdings Full Year 2024 Earnings: EPS: HK$0.11 (vs HK$0.14 in FY 2023)

Simply Wall St.
·
22 Mar

BioInvent’s anti-TNFR2 antibody BI-1808 showcased at the 16th Annual T-Cell Lymphoma Forum

ACCESS Newswire
·
21 Mar

Press Release: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
21 Mar

Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment

Benzinga
·
21 Mar

RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment

ACCESS Newswire
·
20 Mar

CR Construction Group Announces Final Dividend for 2024

TIPRANKS
·
20 Mar

BioInvent Receives FDA Orphan Drug Designation for BI-1808 for the Treatment of T-cell Lymphoma

ACCESS Newswire
·
20 Mar

CR Double-Crane Pharmaceutical 2024 Profit Down 3%; Shares Decline 3%

MT Newswires Live
·
20 Mar

Actinium Pharmaceuticals to Host Investor KOL Call with Dr. Ehab Atallah of the Medical College of Wisconsin and Provide a Pipeline Update Highlighting Revamped Clinical Programs and Expanded Market Opportunities for Actimab-A and Iomab-ACT with Clinical Data in 2H:2025

PR Newswire
·
19 Mar

CR Double-Crane Reports 2024 Financial Results with Dividend Proposal

TIPRANKS
·
19 Mar

Kratos Defense begins building IPIF in Crane, Indiana to support MACH-TB

TIPRANKS
·
19 Mar

Press Release: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Dow Jones
·
19 Mar